Cancer detection
Nucleai has raised €9.9M across 2 funding rounds from 5 investors, most recently a Series A round in Jul 2020. Based in Tel Aviv, Israel; active in AI and Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2020-07-08 | Series A | €5.8M | Debiopharm Innovation Fund | View deal → |
| 2018-01-01 | Other | €4.2M | Brian Cooper,Grove Ventures,Nir Kalkstein,Vertex Ventures Israel | View deal → |
